EE200300232A - Meetodid rekombinantse DNA baasil saadud tPA või K2S molekulide suuremahuliseks tootmiseks - Google Patents

Meetodid rekombinantse DNA baasil saadud tPA või K2S molekulide suuremahuliseks tootmiseks

Info

Publication number
EE200300232A
EE200300232A EEP200300232A EEP200300232A EE200300232A EE 200300232 A EE200300232 A EE 200300232A EE P200300232 A EEP200300232 A EE P200300232A EE P200300232 A EEP200300232 A EE P200300232A EE 200300232 A EE200300232 A EE 200300232A
Authority
EE
Estonia
Prior art keywords
molecules
methods
recombinant dna
scale production
dna based
Prior art date
Application number
EEP200300232A
Other languages
English (en)
Estonian (et)
Inventor
Werner Rolf-G�nther
Goetz Friedrich
Tayapiwatana Chatchai
Manosroi Jiradej
Manosroi Aranya
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of EE200300232A publication Critical patent/EE200300232A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
EEP200300232A 2000-11-14 2001-11-07 Meetodid rekombinantse DNA baasil saadud tPA või K2S molekulide suuremahuliseks tootmiseks EE200300232A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027779.8A GB0027779D0 (en) 2000-11-14 2000-11-14 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
PCT/EP2001/012857 WO2002040650A2 (en) 2000-11-14 2001-11-07 Methods for large scale production of recombinant dna-derived tpa or k2s molecules

Publications (1)

Publication Number Publication Date
EE200300232A true EE200300232A (et) 2003-10-15

Family

ID=9903153

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300232A EE200300232A (et) 2000-11-14 2001-11-07 Meetodid rekombinantse DNA baasil saadud tPA või K2S molekulide suuremahuliseks tootmiseks

Country Status (31)

Country Link
EP (1) EP1407030B1 (cs)
JP (1) JP2004520018A (cs)
KR (1) KR100856346B1 (cs)
CN (1) CN100567495C (cs)
AR (1) AR031334A1 (cs)
AT (1) ATE504652T1 (cs)
AU (2) AU2002221815B2 (cs)
BG (1) BG66121B1 (cs)
BR (1) BR0115344A (cs)
CA (1) CA2428642C (cs)
CZ (1) CZ20031657A3 (cs)
DE (1) DE60144395D1 (cs)
EA (1) EA005163B1 (cs)
EC (1) ECSP034573A (cs)
EE (1) EE200300232A (cs)
GB (1) GB0027779D0 (cs)
HR (1) HRP20030377A2 (cs)
HU (1) HUP0301619A3 (cs)
IL (2) IL155568A0 (cs)
MX (1) MXPA03004161A (cs)
MY (1) MY129838A (cs)
NO (1) NO20032143L (cs)
NZ (1) NZ526280A (cs)
PL (1) PL206783B1 (cs)
SK (1) SK5792003A3 (cs)
TW (1) TWI292782B (cs)
UA (1) UA75102C2 (cs)
UY (1) UY27020A1 (cs)
WO (1) WO2002040650A2 (cs)
YU (1) YU36103A (cs)
ZA (1) ZA200303547B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955910B2 (en) 2000-11-14 2005-10-18 Boehringer Ingelheim International Gmbh Method for large scale production of recombinant DNA-derived TPA or K2S molecules
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
IL190184A0 (en) * 2008-03-16 2009-02-11 Hadasit Med Res Service tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US20020061576A1 (en) * 1997-05-28 2002-05-23 Paul A. Moore Tissue plasminogen activator-like protease
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
GB0027782D0 (en) * 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes

Also Published As

Publication number Publication date
CN100567495C (zh) 2009-12-09
AU2181502A (en) 2002-05-27
BG66121B1 (bg) 2011-05-31
UA75102C2 (en) 2006-03-15
TWI292782B (en) 2008-01-21
IL155568A0 (en) 2003-11-23
HUP0301619A3 (en) 2006-11-28
AU2002221815B2 (en) 2007-08-23
MXPA03004161A (es) 2004-04-20
NO20032143D0 (no) 2003-05-13
WO2002040650A2 (en) 2002-05-23
MY129838A (en) 2007-05-31
SK5792003A3 (en) 2004-01-08
NO20032143L (no) 2003-07-07
CA2428642C (en) 2010-03-30
DE60144395D1 (de) 2011-05-19
PL206783B1 (pl) 2010-09-30
CZ20031657A3 (cs) 2003-10-15
KR20030059252A (ko) 2003-07-07
NZ526280A (en) 2006-02-24
BR0115344A (pt) 2003-08-26
AR031334A1 (es) 2003-09-17
IL155568A (en) 2010-02-17
GB0027779D0 (en) 2000-12-27
HUP0301619A2 (hu) 2003-09-29
PL361881A1 (en) 2004-10-04
ZA200303547B (en) 2004-05-10
EA200300502A1 (ru) 2003-12-25
CA2428642A1 (en) 2002-05-23
EP1407030B1 (en) 2011-04-06
KR100856346B1 (ko) 2008-09-04
HRP20030377A2 (en) 2005-04-30
ECSP034573A (es) 2003-05-26
EA005163B1 (ru) 2004-12-30
BG107780A (bg) 2004-02-27
YU36103A (sh) 2006-05-25
WO2002040650A3 (en) 2003-12-31
ATE504652T1 (de) 2011-04-15
EP1407030A2 (en) 2004-04-14
UY27020A1 (es) 2002-07-31
HK1070097A1 (zh) 2005-06-10
CN1541271A (zh) 2004-10-27
JP2004520018A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
DE60114525D1 (de) Array-basierende Methoden zur Synthese von Nukleinsäuregemischen
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
NO20042159L (no) Cellokulturprosess
DE60208278D1 (de) System und Verfahren zum Testen von Nukleinsäuremolekülen
AU2002350485A1 (en) Device for sequencing nucleic acid molecules
DE60114348D1 (de) Verfahren zur Reinigung von Gasen
ATE454469T1 (de) Für den nachweis von nukleinsäuren kompetente biologische rohderivate
ITMI20030192A1 (it) Sistema catalitico e procedimento per la produzione
BR0309592B8 (pt) sistema de coluna ascendente e processo para construir o mesmo.
WO2003097810A3 (en) Nitrilases, nucleic acids encoding them and methods for making and using them
NO20032822L (no) Fremgangsmate for konsentrering av brukt syre
GB0508052D0 (en) Method to generate or determine nucleic acid tags corresponding the the terminal ends of DNA molecules using sequences analysis of gene expression
AU2003250506A8 (en) Method for the characteristation of nucleic acid molecules
NO20033884L (no) Fremgangsmåte for påvisning av nukleinsyremolekyler
AU2001296491A1 (en) Genotyping by liquid chromatographic analysis of short nucleic acid fragments
EE200300232A (et) Meetodid rekombinantse DNA baasil saadud tPA või K2S molekulide suuremahuliseks tootmiseks
DE60226931D1 (de) Verfahren zur Herstellung von Polyester, Verfahren zur Herstellung von substituierter alpha-Hydroxycarbonsäure und Clostridium beijerinckii-Stamm HICA432
PT1322753E (pt) Novas redutases do acido 2,5-diceto-l-gluconico e metodos de utilizacao
AU2002328909A1 (en) Nucleic acid molecules encoding proteins essential for plant growth
EP1497306A4 (en) NUCLEIC ACID MOLECULES WITH ALTERNATIVE SPLICE
NO20025265D0 (no) Regulatorisk nukleinsyre for ABC1-genet, molekyler som modifiserer dets aktivitet og terapautiske anvendelser
AU2001257255A1 (en) Denaturant-free electrophoresis of biological molecules under high temperature conditions
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor
GB0318354D0 (en) Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereof
DE69918010D1 (de) Methode zum Spalten von spezifischen Nucleinsäuresequenzen